Hematologic ramifications of patent foramen ovale - Role of hypercoagulable state

Cardiology Clinics

Volumn 23, Issue 1, 2005, Pages 65-71

  Hassell, Kathryn L ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBIN; ANTITHROMBOCYTIC AGENT; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; HOMOCYSTEINE; LIPOPROTEIN A; LOW MOLECULAR WEIGHT HEPARIN; PROTEIN C; PROTEIN S; PROTHROMBIN; WARFARIN;

ANTICOAGULATION; ANTITHROMBIN DEFICIENCY; ARTERY THROMBOSIS; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DEVICE; DNA DETERMINATION; DYSFIBRINOGENEMIA; EUGLOBULIN LYSIS TEST; FIBRINOLYSIS; HEART ATRIUM SEPTUM DEFECT; HEART VALVE PROSTHESIS; HUMAN; HYPERCOAGULABILITY; HYPERHOMOCYSTEINEMIA; LOW DRUG DOSE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN DETERMINATION; PROTEIN S DEFICIENCY; REVIEW; STROKE; THROMBIN TIME; THROMBOSIS; TREATMENT INDICATION; VEIN THROMBOSIS;

CEREBROVASCULAR ACCIDENT; FACTOR V; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; PROSTHESES AND IMPLANTS; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 12844261070     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccl.2004.10.002     Document Type: Review

References (36)

1. J. Dearani, B. Ugurlu, and G. Danielson Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events Circulation 100 II 1999 171 175
2. Z.D. Du, Q.L. Cao, and A. Joseph Transcatheter closure of patent foramen ovale patients with paradoxical embolism: intermediate-term risk of recurrent neurological events Catheter Cardiovasc Interv 55 2002 189 194
3. G. Butera, M. Bini, and M. Chessa Transcatheter closure of patent foramen ovale in patients with cryptogenic stroke Ital Heart J 2 2001 115 118
4. F. Martin, P. Sanchez, and E. Doherty Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism Circulation 106 2002 1121 1126
5. S. Windecker, A. Wahl, and T. Chatterjee Percutaneous closure of patent foramen ovale in patients with paradoxical embolism Circulation 101 2000 893 898
6. J. Hung, M. Landzberg, and K. Jenkins Closure of patent foramen ovale for paradoxical emboli: intermediate-term risk of recurrent neurological events following transcatheter device placement J Am Col Cardiol 35 5 2000 1311 1316
7. A. Wahl, B. Meier, and B. Haxel Prognosis after percutaneous closure of patent foramen ovale for paradoxical embolism Neurology 57 2001 1330 1332
8. L. Bruch, A. Parsi, and M.O. Grad Transcatheter closure of interatrial communications for secondary prevention of paradoxical embolism Circulation 105 2002 2845 2848
9. M. Braun, D. Fassbender, and S. Schoen Transcatheter closure of patent foramen ovale in patients with cerebral ischemia J Am Col Cardiol 39 12 2002 2019 2025
10. S. Chaturvedi Coagulation abnormalities in adults with cryptogenic stroke and patent foramen ovale J Neurol Sci 160 1998 158 160
11. P. Cerrato, D. Imperiale, and M. Bazzan Inherited thrombophilic conditions, patent foramen ovale and juvenile ischaemic stroke Cerebrovasc Dis 11 2 2001 140 141
12. M. Meier, and M. Landolt [Family anamnesis as the key to diagnosis. 1. Multi-infarct syndrome in atrial secundum type septal defect. 2. Thrombophilia of uncertain etiology: homocysteine in upper normal range] Schweiz Rundsch Med Prax 89 36 2000 1442 1443 [in German]
13. Lamy C, Giannesini C, Zuber M, et al, for the Patent Foramen Ovale and Atrial Septal Aneurysm Study Group. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: The PFO-ASA study. 2002;33(3):706-11.
14. C. Bushnell, and L. Goldstein Diagnostic testing for coagulopathies in patients with ischemic stroke Stroke 31 2000 3067 3078
15. D.G. Nabavi, R. Junker, and E. Wolff Prevalence of factor V Leiden mutation in young adults and cerebral ischaemia: a case-control study on 225 patients J Neurol 245 1998 653 658
16. A. Folsom, W. Rosamond, and E. Shahar Prospective study of markers of hemostatic function with risk of ischemic stroke Circulation 100 7 1999 736 742
17. Dodge S, Hassell K, Keller J, et al. Arterial hypercoagulability is a common finding in patients referred for percutaneous device closure of patent foramen ovale for secondary prevention of systemic thromboembolization [abstract]. Presented at the American Heart Association 4th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke. November, 2002.
18. K. Nedeltchev, M. Arnold, A. Wahl, and M. Sturzenegger Outcome of patients with cryptogenic stroke and patent foramen ovale J Interv Cardiol 14 2 2001 203 209
19. J.L. Mas, and M. Zuber Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm Am Heart J 130 1995 1083 1088
20. J. Bogousslavsky, S. Garazi, and X. Jeanrenaud Stroke recurrence in patients with patent foramen ovale: the Lausanne study. Lausanne stroke with paradoxic embolism study group Neurology 46 1996 1301 1305
21. R. Roubey Treatment of the antiphospholipid syndrome Curr Opin Rheumatol 14 3 2002 238 242
22. T. Hayes Dysfibrinogenemia and thrombosis Arch Pathol Lab Med 126 11 2002 1387 1390
23. N. Key, and R.C. McGlennen Hyperhomocyst(e)inemia and thrombophilia Arch Pathol Lab Med 126 2002 1367 1375
24. M. von Depka, U. Nowak-Gottl, and R. Eisert Increased lipoprotein(a) levels as an independent risk factor for venous thromboembolism Blood 96 10 2000 3364 3368
25. K. Bauer The thrombophilias: well-defined risk factors with uncertain therapeutic implications Ann Intern Med 135 2001 367 373
26. K.L. Rosee, H.J. Deutsch, and P. Schnabel Thrombus formation after transcatheter closure of atrial septal defect Am J Cardiol 84 1999 356 359
27. C.J. Rodriquez, M.R. Di Tullio, and R.L. Sacco Intra-atrial thrombus after surgical closure of patent foramen ovale J Am Soc Echocardiogr 14 1 2001 63 66
28. O. Gastmann, G. Werner, and U. Babic Thrombus formation on transcatheter ASD occluder device in a patient with coagulation factor XII deficiency Cathet Cardiovasc Diagn 43 1998 81 83
29. V. Stangl, K. Stangl, and J. Bohn Images in cardiothoracic surgery. Thrombus formation after catheter closure of an atrial septal defect with a clamshell Ann Thorac Surg 69 6 2000 1956
30. A.M. Fabricius, M. Krueger, and V. Falk Floating thrombus on an ASD occluder device in a patient with hemophilia A. Thorac Cardiovasc Surg 49 5 2001 312 313
31. V. Nkomo, P. Theuma, and C. Maniu Patent foramen ovale transcatheter closure device thrombosis Mayo Clin Proc 76 2001 1057 1061
32. P. Vermeersch Thrombosis of a patent foramen ovale closure device: thrombolytic management Catheter Cardiovasc Interv 56 2002 522 526
33. M. Greaves Thrombophilia Clin Med 1 2001 432 435
34. J. Levine, W. Branch, and J. Rauch The antiphospholipid syndrome N Engl J Med 346 10 2002 752 763
35. J.P. Mohr, J.L. Thompson, and R.M. Lazar for the Warfarin-Aspirin Recurrent Stroke Study Group A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke N Engl J Med 345 20 2001 1444 1451
36. S. Homma, R. Sacco, and M. Di Tullio for the PFO in Cryptogenic Stroke Study (PICSS) investigators Effect of medical treatment in stroke patients with patent foramen ovale Circulation 105 2002 2625 2631